mToR inhibitors-induced proteinuria: mechanisms, significance, and management (Q37218125)

19 August 2017

1 reference

title

mToR inhibitors-induced proteinuria: mechanisms, significance, and management (English)

1 reference

19 August 2017

Emmanuel Letavernier

1

1 reference

PubMed ID

18631865

19 August 2017

Christophe Legendre

series ordinal

2

1 reference

19 August 2017

1 April 2008

1 reference

19 August 2017

Transplantation Reviews

1 reference

19 August 2017

22

1 reference

19 August 2017

2

1 reference

19 August 2017

125-130

1 reference

Post-transplant renal function in the first year predicts long-term kidney transplant survival

19 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

The natural history of chronic allograft nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

Sirolimus therapy without calcineurin inhibitors: Necker Hospital 8-year experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

Investigation of pediatric renal transplant recipients with heavy proteinuria after sirolimus rescue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

Proteinuria following a switch from calcineurin inhibitors to sirolimus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

Conversion from cyclosporine to sirolimus in stable renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

Conversion to sirolimus from cyclosporine may induce nephrotic proteinuria and progressive deterioration of renal function in chronic allograft nephropathy patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

Unusual post-transplantation recurrence of focal segmental glomerulosclerosis which resolved with cyclosporine but not with sirolimus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

Rapamycin-associated post-transplantation glomerulonephritis and its remission after reintroduction of calcineurin-inhibitor therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

Differences in proteinuria and graft function in de novo sirolimus-based vs. calcineurin inhibitor-based immunosuppression in live donor kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

The renal arterial resistance index and renal allograft survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

Conversion from calcineurin inhibitors to sirolimus in chronic allograft dysfunction: changes in glomerular haemodynamics and proteinuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

The long-term course of cyclosporine-associated chronic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

Kidney Transplantation With Sirolimus and Mycophenolate Mofetil???Based Immunosuppression: 5-Year Results of a Randomized Prospective Trial Compared to Calcineurin Inhibitor Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

Influence of sirolimus on proteinuria in de novo kidney transplantation with expanded criteria donors: comparison of two CNI-free protocols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

High sirolimus levels may induce focal segmental glomerulosclerosis de novo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

Proteinuria following conversion from azathioprine to sirolimus in renal transplant recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

Proteinuria developing after clinical islet transplantation resolves with sirolimus withdrawal and increased tacrolimus dosing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

Sirolimus-associated heavy proteinuria in a renal transplant recipient: evidence for a tubular mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

Sirolimus does not reduce receptor-mediated endocytosis of albumin in proximal tubule cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

Chronic cyclosporin nephropathy: long-term effects of cyclosporin on renal allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

De novo collapsing glomerulopathy in renal allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

Sirolimus-induced thrombotic microangiopathy is associated with decreased expression of vascular endothelial growth factor in kidneys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

Proinflammatory effects in experimental mesangial proliferative glomerulonephritis of the immunosuppressive agent SDZ RAD, a rapamycin derivative

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

Rapamycin worsens renal function and intratubular cast formation in protein overload nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

Mammalian Target of Rapamycin Inhibition Halts the Progression of Proteinuria in a Rat Model of Reduced Renal Mass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

New immunosuppresor strategies in the treatment of murine lupus nephritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

Renoprotective effects of sirolimus in non-immune initiated focal segmental glomerulosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

Factors influencing glomerular filtration rate in renal transplantation after cyclosporine withdrawal using sirolimus-based therapy: a multivariate analysis of results at five years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

Acute rapamycin nephrotoxicity in native kidneys of patients with chronic glomerulopathies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

Sirolimus Prolongs Recovery from Delayed Graft Function After Cadaveric Renal Transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

Sirolimus Therapy of Focal Segmental Glomerulosclerosis Is Associated With Nephrotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

A prospective, open-label trial of sirolimus in the treatment of focal segmental glomerulosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

Conversion from a calcineurin inhibitor-based immunosuppressive regimen to everolimus in renal transplant recipients: effect on renal function and proteinuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

Everolimus versus mycophenolate mofetil in the prevention of rejection in de novo renal transplant recipients: a 3-year randomized, multicenter, phase III study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRRE.2007.12.001

10.1016/J.TRRE.2007.12.001

7 January 2021

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

18631865